164 related articles for article (PubMed ID: 25222239)
1. Correlation between hepcidin level and renal anemia.
Yang LN; Zhang P; Tang F; Wang G; Li FE
Genet Mol Res; 2014 Sep; 13(3):7407-10. PubMed ID: 25222239
[TBL] [Abstract][Full Text] [Related]
2. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
[TBL] [Abstract][Full Text] [Related]
4. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
[TBL] [Abstract][Full Text] [Related]
5. Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.
Niihata K; Tomosugi N; Uehata T; Shoji T; Mitsumoto K; Shimizu M; Kawabata H; Sakaguchi Y; Suzuki A; Hayashi T; Okada N; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Dec; 27(12):4378-85; discussion 4384-5. PubMed ID: 22833619
[TBL] [Abstract][Full Text] [Related]
6. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
Xue D; He X; Zhou C
Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
[TBL] [Abstract][Full Text] [Related]
7. Association of hepcidin and anemia in early chronic kidney disease.
Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
[TBL] [Abstract][Full Text] [Related]
8. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease].
Han X; Zhou DB; Duan MH; Wang X; Zhang JP; Zhao YQ; Shen T; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):403-9. PubMed ID: 23628042
[TBL] [Abstract][Full Text] [Related]
10. Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.
Samouilidou E; Pantelias K; Petras D; Tsirpanlis G; Bakirtzi J; Chatzivasileiou G; Tzanatos H; Grapsa E
Ther Apher Dial; 2014 Jun; 18(3):279-83. PubMed ID: 24119290
[TBL] [Abstract][Full Text] [Related]
11. Serum hepcidin level and its clinical significance in maintenance hemodialysis patients.
Zhang P; Yang LN; Wang G; Li FE; Tang F
Genet Mol Res; 2014 Nov; 13(4):9883-8. PubMed ID: 25501198
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease.
Basseri RJ; Nemeth E; Vassilaki ME; Basseri B; Enayati P; Shaye O; Bourikas LA; Ganz T; Papadakis KA
J Crohns Colitis; 2013 Sep; 7(8):e286-91. PubMed ID: 23219355
[TBL] [Abstract][Full Text] [Related]
13. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis.
Antunes SA; Vilela RQ; Vaz JD; Canziani ME
Int J Artif Organs; 2014 Jul; 37(7):521-8. PubMed ID: 25044383
[TBL] [Abstract][Full Text] [Related]
15. Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease.
Chand S; Ward DG; Ng ZY; Hodson J; Kirby H; Steele P; Rooplal I; Bantugon F; Iqbal T; Tselepis C; Drayson MT; Whitelegg A; Chowrimootoo M; Borrows R
J Nephrol; 2015 Feb; 28(1):81-8. PubMed ID: 24687402
[TBL] [Abstract][Full Text] [Related]
16. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
17. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease.
Lukaszyk E; Lukaszyk M; Koc-Zorawska E; Bodzenta-Lukaszyk A; Malyszko J
Int Urol Nephrol; 2018 Jan; 50(1):121-125. PubMed ID: 29134616
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease.
Min HK; Sung SA; Oh YK; Kim YH; Chung W; Park SK; Ahn C; Lee SW
Nephrol Dial Transplant; 2020 Jan; 35(1):147-154. PubMed ID: 30053139
[TBL] [Abstract][Full Text] [Related]
19. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X
Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]